Skip to Main Content

NISH (NITAG Support Hub) 4: HPV OR Human Papillomavirus Vaccines: Latest publications

This Library Guide is a collection of useful documents & evidence on the efficacy, effectiveness and impact of the HPV OR Papillomavirus vaccine to support NITAG members and other policy makers throughout Africa with making evidence-based recommendations

Latest publications

Tesfom, H.N., Gizaw, M., Yilam, M. et al.  (2025). Prevalence and factors associated with high-risk human papillomavirus infection and cervical lesions among women with HIV in Addis Ababa, Ethiopia. BMC Cancer 25, 1557. https://doi.org/10.1186/s12885-025-14832-3

Abdelhadi, L. M., Aryan, F. S., Alsabi, R., Samhan, G. A., & Al-Qaaneh, A. M. (2025). Knowledge, Attitudes, and Practices Associated with Human Papillomavirus Vaccine Recommendation Among Healthcare Professionals: A Cross-Sectional Study. Infectious Disease Reports, 17(5), 126. https://doi.org/10.3390/idr17050126

Kim, S. K., Duncan, R., Chittams, J., & Teitelman, A. M. (2025). Evaluating Now I Know mHealth intervention promoting HPV vaccine completion among young women attending federally supported clinics. Cancer Causes & Control, 1-12. https://doi.org/10.1007/s10552-025-02046-8

Celestina V. Antunes , Aysha G. Pires , Oriana Barros , Ariana DePina , Qun Le & Ana Cristina Lindsay (2025) Human papillomavirus (HPV) awareness, knowledge, and vaccine uptake among Cape Verdean immigrant parents in the United States: A community-based, cross-sectional study, Human Vaccines & Immunotherapeutics, 21:1, 2561410, https://doi.org/10.1080/21645515.2025.2561410

Patel, C., & Brotherton, J. (2025). Monitoring the benefits of human papillomavirus vaccination in low-income and middle-income countries. The Lancet Global Health13(10), e1657-e1658.https://www.thelancet.com/action/showPdf?pii=S2214-109X%2825%2900327-4

Cerqueira-Silva, T., Barral-Netto, M., & Boaventura, V. S. (2025). Effect of Brazil's national human papillomavirus vaccination programme on the incidence of cervical cancer and cervical intraepithelial neoplasia grade 3 in women aged 20–24 years: a population-based study. The Lancet Global Health13(10), e1715-e1722. https://www.thelancet.com/action/showPdf?pii=S2214-109X%2825%2900279-7

Ye, M., Yan, D., Xu, J., Liu, D., Liu, X., Jiang, W., ... & Huang, W. (2025). Human papillomavirus prevalence and genotype distribution among 30,147 screened women and 3,362 cervical cancer patients in China: a retrospective study. Virology Journal, 22(1), 1-12. https://doi.org/10.1186/s12985-025-02943-z